The goals of this proposal are to investigate the in vitro properties and in vivo function of TFII-I. TFII-1 is required for transcription initiation from many TATA-less promoters that instead contain an initiator element. This factor is also thought to provide for the integration of basal and regulatory transcription signals at these promoters. TFII-I contains 6 tandemly repeated HLH motifs that may mediate different protein/protein and protein/DNA interactions. The objectives of the proposal include detailed analysis of the functions of TFII-I employing DNA binding studies, binding site selection, in vitro transcription and in vitro mutagenesis. Determining the structure of TFII- I will be approached by Biochemical and Biophysical methods including high resolution crystallographic analysis. The proposal also includes investigations into the apparent regulation of TFII-I by phosphorylation in vivo and in vitro by phosphopeptide fingerprinting, in vitro mutagenesis and by employing dominant negatives of MAPK. The function of TFII-I at the V beta Inr element will be analyzed in vivo (in animal cells) using wild type and mutant TFII-I protein as well as V beta derived promoter constructs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI041147-01A1
Application #
2767439
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1998-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
2000-05-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Tufts University
Department
Pathology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111